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To assess the role of the immune system in cardiac allograft vasculopathy 
in large animals, heterotopic heart transplantation was done between 
partially inbred miniature swine, animals in which transplantation can be 
done across defined major histocompatibility barriers in a reproducible 
fashion. Porcine hearts transplanted into untreated recipients across a 
class I, class II, or full major histocompatibility mismatch were acutely 
rejected in 6 to 8 days (n = 4). Hearts transplanted into untreated 
recipients across minor histocompatibility barriers survived for 21 to 44 
days (n = 5) and showed no evidence of cardiac allograft vasculopathy. 
When recipients were treated with a 12-day course of cyclosporine, hearts 
transplanted across minor histocompatibility barriers survived 42, 64, and 
56 days and did not develop vascular lesions. However, hearts transplanted 
into cyclosporine-treated r cipients across a full major histocompatibility 
disparity survived 20, 22, and 23 days and all three developed biopsy- 
proven vasculopathy. In one animal, the progression of intimal prolifera- 
tion was followed in vivo by intracoronary ultrasonography. The degree of 
intimal thickening documented by ultrasonography correlated well with the 
intimal proliferation found on tissue histologic samples. These r sults are 
the first to show that in large animals, an immune response stimulated by 
donor major histocompatibility antigens is involved in the induction of 
cardiac allograft vasculopathy. In addition, these studies point out the 
utility of a large-animal model of cardiac allograft vasculopathy in which 
transplantation across defined major histocompatibility barriers can be 
done reproducibly and in which accurate determinations of the progression 
or regression of coronary vascular lesions in individual animals can be 
accurately assessed in vivo. (J Thorac Cardiovasc Surg 1996;111:1230-9) 
T he short-term results of heart transplantation have improved dramatically during the past 25 
years with survival rates at 1 year increasing from 
22% in 19691 to more than 80% in 1993. a However, 
the progress made in the detection, prevention, and 
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treatment of acute rejection has been overshadowed 
by the poorly understood problem of cardiac al- 
lograft vasculopathy (CAV). This disease is mani- 
fested by a diffuse and accelerated form of athero- 
sclerosis that often involves entire lengths of 
coronary arteries. Autopsy findings reveal that vir- 
tually all transplant recipients who survive for more 
than a year demonstrate intimal changes. 3 Indeed, 
in many series, CAV is the leading cause of death or 
graft failure after the first posttransplant year. 4 
Nonetheless, the cause of CAV remains a mystery 
and at present here is no effective treatment for this 
disease. 
Experimental studies investigating the immuno- 
logic basis of CAV have been primarily done in 
rodent models with the use of whole-organ or 
arterial allografts. 5 Although these studies have 
yielded important information, many of the results 
from experiments that attemped to elucidate the 
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potential immune mediators of CAV have been 
conflicting. Some studies have implicated antibodies 
specific for donor antigens in the development of 
intimal proliferation in rodents, 6 whereas others 
have supported the predominance of T cell-medi- 
ated immunity directed against the host 7 or acti- 
vated macrophages. 8 Of course, it is possible that 
multiple forms of immunity might participate in the 
pathogenesis of CAV. 
To investigate the immunobiologic basis of CAV 
in large animals, we performed heterotopic heart 
transplants between partially inbred miniature 
swine. Miniature swine bring several unique advan- 
tages to the study of CAV. Unlike those of rodents, 
the porcine immune and cardiovascular systems are 
similar to those of human beings, as is the porcine 
susceptibility to atherosclerosis. 9-1I Transplantation 
across defined major histocompatibility (MHC) bar- 
riers can be done reproducibly in these animals, 
making it possible to study the dependence of CAV 
on MHC genetics. 12 Also, the coronary arteries of 
the transplanted heart are large enough to be im- 
aged with intracoronary ultrasonography (ICUS), 
making miniswine the only experimental model of 
CAV in which the effects of treatment can be 
accurately assessed in vivo. 
In this article we describe and validate a large- 
animal, preclinical model of CAV with the use of 
miniature swine, which develop vascular lesions 
identical to those observed in clinical transplanta- 
tion. Data are presented that support he hypothesis 
that the induction of CAV in large animals is 
mediated by an immune response stimulated by 
MHC antigen. 
Material and methods 
Animals. During the past 25 years, a selective breeding 
program has been used to develop and maintain miniature 
swine with defined MHC loci (termed SLA, for swine 
leukocyte antigens) as a large-animal model for studies of 
transplantation biology, la At present, swine of three ho- 
mozygous MHC haplotypes, SLA a, SLA c, and SLA a, are 
maintained (Fig. 1). In addition, swine bearing four 
intra-MHC recombinant haplotypes have been derived by 
spontaneous recombination events during the breeding of 
heterozygotes a  part of the breeding program (Fig. 1). 13 
Genotyping has been controlled by strict pedigree breed- 
ing and confirmed by microcytotoxicity testing with al- 
lospecific antisera. 
All animal care and procedures were in compliance 
with the "Principles of Laboratory Animal Care" formu- 
lated by the National Society for Medical Research and 
the "Guide for the Care and Use of Laboratory Animals" 
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Fig. 1. Origin of available MHC haplotypes of partially 
inbred miniature swine. 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). 
Heterotopic cardiac transplants. Transplant donors 
and recipients (4 to 6 months old and weighing between 15 
and 40 kg) were fasted overnight, then sedated with 
ketamine (20 mg/kg), butorphanol (Torbugesic, 0.2 rag/ 
kg), and xylazine (2 mg/kg) intramuscularly for scrubbing, 
shaving, and intubation. Anesthesia was maintained with 
halothane 1%, NaO 1%, and O a. The recipient was placed 
in the left lateral decubitus position and a Hickman 
catheter was placed in the left external jugular vein for 
long-term vascular access. A left flank incision was done 
and, by a retroperitoneal pproach, the infrarenal aorta 
and inferior vena cava were isolated. Next, the donor was 
systemically heparinized (3 mg/kg) and the donor heart 
harvested after cardiac standstill was achieved with cold 
(4 ° C) cardioplegic solution (Plegisol, Abbott Laborato- 
ries, North Chicago, Ill.). An atrial septal defect was 
created in each donor heart and the mitral valve defunc- 
tionalized to minimize left ventricular atrophy and intra- 
cavitary thrombus formation. 14' 15 The recipient was sys- 
temically heparinized (3 mg/kg) and the donor pulmonary 
artery was anastomosed end-to-side to a 1 to 2 cm 
venotomy in the inferior vena cava with a continuous 6-0 
polypropylene suture (Prolene, Ethicon, Inc., Somerville, 
N.J.). Next, the ascending aorta of the donor heart was 
anastomosed to the recipient's abdominal aorta in a 
similar manner. A 2 to 4 mm cuff of aortic wall was 
resected around the aortotomy before construction of the 
anastomosis to avoid stricture formation. Neither cold 
ischemic times nor warm ischemic times exceeded 45 
minutes. In most cases, removal of the aortic crossclamp 
resulted in spontaneous conversion to a normal sinus 
rhythm. However, in some cases internal electrical defi- 
brillation (10 to 20 joules) was necessary. Before closure 
of the abdominal wall, iridium-tipped ventricular elec- 
trodes (model 6500 pacing lead, Medtronic Inc., Secaucus, 
N.J.) were implanted into each ventricle and brought out 
through the skin for long-term electrocardiographic mon- 
itoring. 
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Table I. Pathologic grading of heart tissue from 
biopsy or necropsy samples 
Grade 
Histologic evidence of arterial intimal thickening 
Normal artery 0 
<10% occlusion of lumen by intimal prolifera- 1 
tion or inflammatory cells 
>10% but <50% occlusion of lumen 2 
>50% occlusion of lumen 3 
Histologic evidence of interstitial rejection 
No rejection 0 
Focal (perivascular/interstitial) infiltrate without la 
necrosis 
Diffuse but sparse infiltrate without necrosis lb 
One focus only with aggressive infiltration, focal 2 
myocyte damage, or both 
Multifocal aggressive infiltrates, myocyte dam- 3a 
age, or both 
Diffuse inflammatory process with necrosis 3b 
Diffuse aggressive polymorphous infiltrate with 4 
or without edema, with or without hemorrhage, 
with or without vasculitis, with necrosis 
Heart function was monitored by transabdominal pal- 
pation, electrocardiography (EK/5A, Burdick Corp., Mil- 
ton, Wis.), and echocardiography (Sonos 1500, Hewlett- 
Packard, Andover, Mass.). Allograft rejection (heart 
survival time) was defined by one or more of the follow- 
ing: lack of a ventricular impulse on palpation, an R wave 
of less than 3 mm amplitude on electrocardiography, or 
lack of ventricular contraction on echocardiography. After 
allograft rejection, the animal was put to death and the 
allograft harvested for histologic examination. 
On posttransplant days 7, 14, 21, 28, and 50 percutane- 
ous biopsy samples of the transplanted heart were ob- 
tained with a spring-loaded biopsy device (Monopty, 
Waltham, Mass.) with ultrasonographic guidance. On 
posttransplant days 8 and 21, animal No. 11531 underwent 
ICUS to validate its applicability. 
Most of the inbred miniature swine herd is seropositive for 
porcine cytomegalovirus (personal communication, Dr. Jay 
A. Fishman). Cholesterol levels in the recipients remained 
consistently low before and after transplantation. 
Coronary hemodynamics. Blood pressure was trans- 
duced via a 25-gauge needle inserted directly into the 
proximal left anterior descending artery (LAD) before the 
first diagonal branch. Blood flow was measured with an 
ultrasonic flow probe (Transonics Systems, Ithaca, N.Y.) 
placed circumferentially around the proximal LAD. 
Histopathologic examination. Heart tissue from bioPsY 
or necropsy specimens was fixed in 10% formalin. The 
graft tissues were embedded in paraffin and then stained 
with hematoxylin and eosin or Masson's trichrome stain. 
An effort was made to examine a range of vessels in the 
transplanted heart, including epicardial and muscular 
arteries and arterioles. Histologic findings were scored 
with the use of light microscopy to determine the severity 
of interstitial rejection, which was based on a modification 
of the International Society for Heart and Lung Trans- 
Table II. Effects of MHC matching on cardiac 
alIografi survival in untreated miniswine* 
Recipient MHC Strain Survival 
No. mismatch combination (days) 
830 Full MHC ag --~ cc 7 
828 Full MHC ag -~ cc 8 
2513 Class I ad -~ ag 8 
2511 Class II cc -~ ag 6 
2499 None cc -~ cc 35 
2502 None cc -~ cc 39 
818 None cc -~ cc 28 
828 None cc -~ cc 44 
10607 None dd --~ dd 21 
*All control animals underwent transplantation by Dr. Chris Stone (see 
Stone and associates 29)except no. 10607. 
plantation system, 16 and the degree of arterial intimal 
thickening, which was based on the system described by 
Lurie and colleagues 17(Table I). The average grade of 
intimal thickening of all small, medium, and large arterial 
vessels was determined and labeled "mean average in- 
volvement. ''la All histologic sections were read in a 
blinded manner. 
Immunosuppressiou. Cyclosporine was generously 
provided by Sandoz (Hanover, N.J.). Cyclosporine was 
administered to designated recipients intravenously be- 
ginning on the day of operation (postoperative day 0) and 
continuing until posttransplant day 11. Cyclosporine 
blood levels (fluorescence polarization immunoassay) 
were maintained between 500 and 1000 ng/ml by varying 
the cyclosporine dosage between 10 and 13 mg/kg per day. 
This regimen has proved effective in prolonging the 
survival of SLA class ! kidney transplants in miniature 
swine. 19 
ICU$. The right or left carotid artery was accessed 
via cutdown under sterile conditions. An 8F guiding 
catheter was inserted into the ostium of the left main 
coronary artery under fluoroscopic guidance. Coronary 
angiography was done in orthogonal views with the use 
of 50% Hypaque preparation. ICUS imaging was ob- 
tained with a 2.9F ultrasonography catheter (Cardio- 
vascular Imaging Systems, Sunnyvale, Calif.) with a 30 
MHz transducer rotating at 1800 RPM to produce a 
360-degree tomographic image. This catheter has an 
axial and lateral resolution of 150 /xm or less. After 
placement of a 0.014-inch guide wire into the LAD, the 
ICUS catheter was advanced over the wire under 
fluoroscopic guidance to a segment of the LAD previ- 
ously marked with a titanium clip at the time of 
transplantation. 
Imaging was begun as the transducer was withdrawn at 
1 mm/sec with use of a motorized pullback device and 
terminated when the aorto-ostial junction of the LAD was 
reached. Use of a motorized pullback allowed proper 
alignment of images proximal to the titanium marker so 
that images from the same location within the artery could 
be accurately compared at different imes. A motorized 
pullback also allowed three-dimensional reconstruction f 
the tomographic mages by a commercially available pro- 
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Table III. Cardiac allograft survival and evolution of lesions in cyclosporine-treated* miniswine bearing MHC- 
matched or MHC-mismatched hearts 
Heart histologic findings 
MHC Animal Strain Sulvival 
mismatch No. combination Week 1 Week 2 Week 3 Week >~6 (days) 
None 
Full 
10686 dd -~ dd Vascular: 0 0 0 0 56~ 
Interstitial: 2 3a 3a 3a 
11252 dd -~ dd Vascular: 0 0 0 0 42 
Interstitial: la  la  3b 3b 
11588 gg --> gg Vascular: 0 0 0 0 64 
Interstitial: 3a la  lb 3b 
11531 cc -~ dd Vascular: 0 0 3 23 
Interstitial: lb lb 4 
11597 cc --~ dd Vascular: 0 0 3 22 
Interstitial: lb lb 3b 
10598 cc ~ dd Vascular: 0 0 2 20 
Interstitial: 3a 3b 3b 
*Cyclosporine 10 to 13 mg/kg on days 0 through 11. 
~'Stenotic aortic anastomosis noted at necropsy. 
gram (INDEC System, Capitola, Calif.). All images were 
recorded on Vz-inch VHS videotape for further analysis. 
Measurements were made from images at four discrete 
locations in the LAD or left main coronary artery. The 
following dimensions were measured at end-systole: 
minimal uminal diameter, luminal area, arterial area 
(defined as the area enclosed by the media-adventitial 
border), maximal intimal thickness for each quadrant, 
and plaque area (defined as arterial area minus luminal 
area). Intimal changes were classified as minimal, mild, 
moderate, and severe by the classification of St. Goar 
and associates. 2° 
Results 
Cardiac allograft survival in untreated recipients. 
Hearts transplanted across a full MHC mismatch 
underwent severe, acute rejection with survival 
times of 7 and 8 days (Table II). Similarly, hearts 
transplanted across a single-haplotype class I dispar- 
ity and a two-haplotype class II disparity were 
acutely rejected in 8 and 6 days, respectively. Match- 
ing for the SLA, on the other hand, led to prolonged 
survival (mean survival, 33.4 days), with one graft 
surviving 44 days. None of the SLA-matched hearts 
went on to long-term survival, most likely because of 
minor histocompatibility antigen disparities. Histo- 
logic examination of these hearts at necropsy re- 
vealed no evidence of intimal thickening (personal 
communication, Dr. Chris Stone). These results 
demonstrated that both major and minor histocom- 
patibility antigens present strong barriers to heart 
transplantation in the pig and that immunosuppres- 
sive therapy would be necessary to prolong graft 
survival and permit the development of vascular 
lesions. 
Cardiac aliograft survival and development of 
CAV in cyclosporine-treated recipients. Cyclospo- 
fine was chosen for immunosuppression because of 
its clinical relevance and because a cyclosporine 
dose-response r lationship had already been estab- 
lished in miniswine for kidney transplantation, t9 
First, three SLA-matched hearts were trans- 
planted into recipients treated with a 12-day course 
of cyclosporine (10 to 13 mg/kg). Allograft rejection 
was only minimally delayed as compared with that in 
MHC-matched grafts transplanted into untreated 
recipients (compare Tables II and III). Histologic 
examination ofbiopsy and necropsy specimens from 
these cyclosporine- treated, MHC-matched hearts 
revealed no intimal thickening in either large or 
small coronary arteries (Table III). 
In contrast, when hearts were transplanted into 
cyclosporine-treated r cipients across a full MHC 
mismatch, dramatic proliferation of the coronary 
artery intima was observed in each case even though 
graft survival times were shorter (20 to 23 days) 
(Table III). Early lesions exhibited proliferation of 
spindle cells and matrix in the intima of arteries and 
arterioles, which resulted in a marked thickening of 
this layer as compared with findings in normal hearts 
(Fig. 2, compare A and B). Later lesions demon- 
strated deposition of lipid and progressive intimal 
fibrosis, which in many cases occluded the lumens of 
both large (Fig. 2, C) and small (Fig. 2, D) arteries. 
The frequency with which the coronary arteries in 
tissue sections from cyclosporine-treated, MHC- 
mismatched hearts demonstrated intimal thickening 
was 70% to 95%. 
1234 Madsen et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
June 1996 
Fig. 2. Photomicrographs of coronary arteries. A, Normal heart stained with hematoxylin and eosin stain 
(original magnification ×400)i B, heart No. 11531 stained with hematoxylin and eosin (original magnifi- 
cation ×400); C, heart No. 11597 stained with trichrome lastic stain (original magnification ×400); D, 
heart No. 10598 stained with trichrome stain (original magnification × 600. Arrows indicate internal elastic 
lamina. L, Lumen; I, intima; M, media; A, adventitia. 
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Fig 3. ICUS and histologic section f LAD of allograft No. 11531 at posttransplant day 8 (A) and 21 (B). 
Black central circle is ultrasonographic catheter surrounded by lumen. Graphic representation of
ultrasonographic image is beneath actual ultrasonogram (C and D). E, Hematoxylin and eosin-stained 
section of normal LAD; F, section through area in region of LAD from No. 11531 that corresponded with 
area imaged by ICUS (original magnification ×400). 
Imaging with ICUS. ICUS was done in the LAD 
of recipient No. 11531 on posttransplant days 8 and 
21 (Fig. 3). On posttransplant day 8, no intimal 
thickening was observed (Fig. 3, A and C). The 
thickness of the intima and media was essentially at 
the resolution of the ultrasonographic catheter (150 
/xg) and therefore not visualized. However, by post- 
transplant day 21, repeat ICUS in a similar location 
revealed the development of intimal hyperplasia in 
more than half the circumference of the vessel wall 
(Fig. 3, B and D). The increase in intimal thickness 
measured approximately 0.5 mm, which represents a 
severe change according to the classification of St. 
Goar and associates. 2° After necropsy, photomicro- 
graphs were obtained of the LAD from recipient 
No. 11531 in the same region imaged by ICUS. A 
similar degree of eccentric intimal thickening was 
observed (Fig. 3, F). By way of comparison, Fig. 3, E, 
represents a section of normal LAD from a naive 
pig. The slight differences in the overall thickness of 
the intima and media in the ICUS images as com- 
pared with that in the histologic sections were 
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probably related to differences in the location of 
ICUS imaging versus tissue sectioning. 
Characteristics of coronary artery blood flow in 
the native and heterotopically transplanted heart. 
Coronary artery hemodynamics in native miniswine 
hearts were compared with coronary flow character- 
istics in heterotopically transplanted hearts. Table 
IV depicts the mean blood pressure and blood flow 
in the LAD of the hearts from donors No. 11043 and 
11613 in the native position (before donor cardiec- 
tomy) and in the heterotopic position 5 minutes 
after the aortic crossclamp was removed. The results 
show that heart rate, mean aortic blood pressure, 
mean LAD blood pressure, and mean LAD flow all 
increased proportionately in the heterotopic heart 
after transplantation (Table IV). These hemody- 
namic changes were probably related to postisch- 
emic hyperemia in the vascular bed of the trans- 
planted heart and the higher systemic blood 
pressure in the recipient. 
Discussion 
This study demonstrated the feasibility and ad- 
vantages of studying CAV in partially inbred 
miniature swine. In cyclosporine-treated mini- 
swine, obstructive coronary lesions developed in 
hearts transplanted across a full MHC barrier but 
not in cardiac allografts matched at the MHC. 
The florid vascular lesions, as well as the deposi- 
tion of lipid, that developed within 4 weeks of 
transplantation i  the coronary arteries of MHC- 
mismatched hearts appeared indistinguishable 
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Table IV. Mean blood pressure and flow in LAD of 




Hear t  rate (beats/min) 56/42 95/86 
Ascending aortic pressure (mm Hg) 48/55 66/71 
LAD pressure (mm Hg) 34/44 56/61 
LAD flow (ml/min) 40/37 53/52 
from atherosclerotic lesions observed in long- 
term human cardiac grafts. Although results from 
rodent experiments have led to the view, now 
rather widely held, that immune phenomena un- 
derlie CAV, these findings are the first that 
indicate that MHC histoincompatibility between 
donor and recipient is important in the develop- 
ment of CAV in large animals. 
The distinction between large animals (including 
human beings) and small animals is important be- 
cause significant differences exist between the im- 
mune systems and cardiovascular systems of these 
two groups and in their susceptibility o atheroscle- 
rosis. 9 For instance, it has been demonstrated that 
rodents do not constitutively express MHC class II 
antigens on their vascular endothelium, whereas 
large animals and human beings do. 21' 22 Given the 
crucial role that class II antigens play in allograft 
rejection, 23 these interspecies differences may be 
important in both early and late alloresponses. 24 In 
terms of atherosclerosis, there is evidence that the 
vigor of an atherogenic response after endothelial 
injury varies greatly, not only between small animal 
species, 1° but even between different strains within 
the same rodent species. 14 Moreover, rat coronary 
arteries have no vasa vasorum, a much thinner 
intimal layer, and a lower elastin content than 
human or porcine vessels. 2s 
Obviously, the availability of inbred and trans- 
genic rodents, specifically mice, constitutes an im- 
portant resource for genetic and "knock-out" exper- 
iments. However, the vascular lesions that develop 
in murine coronary arteries differ from those ob- 
served in the human being and pig with respect o 
the lack of lipid deposition i  the intimal layer of the 
vessel wall. 5' 18 Also, nonvascularized arterial trans- 
plants, used in some of these experiments, 26 elicit a 
different alloresponse than that generated by a 
vascularized organ allograft. 5'27 Finally, the inter- 
pretation of immune events that take place in 
rodent models of CAV has been based primarily 
Table ¥. Comparison of rodent and pig models of 
CAV 
Mouse Rat Pig 
1. Def ined genetics + + + + 
2. Vascular class I I  expression* - + / -  + + 
3. Int imal  l ipid deposit ion* - '~ - + 
4. Nontransplant  atherosclerosis* -~" - + 
5. MAbs /DNA probes + + + + + + 
6. Transgenic animals + - - 
7. Serial lymphohemopoiet ic  sampl ing - + 
8. Serial biopsies - + 
9. In vivo ICUS imaging - - + 
10. Assessment of coronary hemodynamics  - - + 
11. PET /MRI  scanning - +/  + 
12. Orthotopic  transplantat ion - - + 
MAbs, Monoclonal antibodies; DNA, deoxyribonucleic acid; PET, positron 
emission tomography; MRI, magnetic resonance imaging. 
*Present in human beings. 
~'Present in the ApoE knock-out strain, s 
on the histologic and morphologic findings of 
graft tissue samples instead of on serial in vitro 
testing of specific immune ffector functions or on 
in vivo assessment of the progression of intimal 
thickening. 
Because they are large animals, miniature swine 
are uniquely suited to the study of the immunobiol- 
ogy of CAV (Table V). The porcine MHC has been 
well-characterized, making it possible to transplant 
hearts across defined MHC barriers reproducibly. 12 
In addition, various MHC mismatches can be tested 
with use of a single recipient strain, thus minimizing 
strain-specific variations in atherogenesis and im- 
mune responsiveness (Ir gene effects). Unlike that in 
rodents, porcine coronary endothelium constitu- 
tively expresses class II antigens, similar to this 
expression in human beings (J. C. M., manuscript 
submitted). Swine resemble human beings in their 
cardiovascular physiologic makeup 9 and in their 
susceptibility to nontransplant atherosclerosis. I1 
The porcine lymphohematopoietic system allows 
multiple samplings so that longitudinal nalyses of 
immune ffector functions can be done in individ- 
ual animals with the use of swine-specific mono- 
clonal antibodies and cytokine probes. Similarly, 
the porcine heart is large enough to allow re- 
peated biopies, orthotopic transplantation, and 
serial imaging with ICUS. Miniature swine pro- 
vide the only experimental model of CAV in 
which the effects of treatment can be accurately 
assessed in vivo. 
The difference in arterial obstructive l sions be- 
tween MHC-matched and MHC-mismatched grafts 
1 2 3 8 Madsen et al. 
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in our model supports the hypothesis that a persis- 
tent, low-grade immunologic njury to coronary ar- 
tery walls induces the coronary endothelium to 
respond with a similar inflammatory-fibroprolifera- 
tive reaction to that observed in nontransplant ath- 
erosclerosis. In addition, the observation that both 
MHC-matched and MHC-mismatched hearts un- 
derwent interstitial rejection suggests that although 
the immune mechanisms responsible for initiating 
CAV were MHC driven, they may well have been 
different from the mechanisms that stimulated 
interstitial rejection. The observation of the 
former lesion clinically in association with chronic 
graft loss and that of the latter with acute graft 
loss further suggests that the afferent mechanisms 
that mediate acute and chronic rejection may 
differ. Of note, the possibility that porcine cyto- 
megalovirus contributed to the development of 
vascular lesions in these studies has not been 
ruled out and awaits the determination of donor 
and recipient porcine cytomegalovirus status for 
each transplant. 
Miniature swine will allow us to dissect further the 
effects of MHC class I versus class II antigen 
disparities on the induction of CAV and to study the 
effects of therapy in vivo. Preliminary data in this 
large-animal system suggest that, unlike conditions 
in some rodent models, 2s MHC class I antigen 
disparities play an important role in the develop- 
ment of vascular lesions (J. C. M., manuscript 
submitted). We plan to evaluate whether induction 
of tolerance to donor class I antigens 19can prevent 
cardiac allograft vasculopathy in this model. 
We wish to thank Drs. Paul S. Russell, Robert B. 
Colvin, and Tomasz Sablinski for their critical review of 
this manuscript. 
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